viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Amoxicillin sodium / clavulanic acid
keemiline struktuur
Kaubanduslikud nimed erinevates maades
Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist
Aktil
Ungari
Amoclan
Saudi Araabia
Amoklavin
Türgi
Amoksiklav
Poola
Amoxclav
Saudi Araabia
Amplamox
Brasiilia
Augmentin
Araabia Ühendemiraadid, Austria, Belgia, Ecuador, Hispaania, Holland, Itaalia, Kreeka, Poola, Prantsusmaa, Saudi Araabia, Suurbritannia, Sveits, Tšiili, Türgi
Betamox
Portugal
Clavamox
Austria
Clavicin
Malaisia, Venetsueela
Clavulin
Brasiilia
Co-amoxi
Sveits
Co-Amoxicillin
Sveits
Curam
Saudi Araabia, uus-Meremaa
Darzitil
Argentiina
Dibional
Argentiina
Julmentin
Araabia Ühendemiraadid
Novamox
Brasiilia
Sulbamox
Tšiili
Tarometin
Poola
Trifamox
Argentiina, Ecuador, Kolumbia, Mehhiko
Viited : Amoxicillin sodium / clavulanic acid
tüüp
avaldamine
186
ajaleht
Swart EL, Mooren RAG, Van Loenen AC.
Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
889
ajaleht
Janknegt R, Stratermans T, Cilissen J, Lohman JJHM, Hooymans PM.
Ofloxacin intravenous. Compatibility with other antibacterial agents.
Pharm Weekbl [Sci] 1991 ; 13: 207-209.
1318
ajaleht
Ashwin J, Lynn B, Taskis CB.
Stability and administration of intravenous Augmentin.
Pharm J 1987 ; 238: 116-118.
1357
ajaleht
Janknegt R, Schrouff GGM, Hooymans PM, Hermens WJHH, Lohman JJHM.
Quinolones and penicillins incompatibility.
Ann Pharmacotherapy 1989 ; 23: 91-92.
1746
ajaleht
Kambia N, Merite N, Dine T, Dupin-Spriet T, Gressier B, Luyckx M, Watinne C, Brunet C.
Stability studies of amoxicillin/clavulanic acid combinaison in polyolefin infusion bags.
EJHP 2010 ; 16, 30-37.
2139
ajaleht
Serrurier C, Chenot ED, Vigneron J, May I, Demor? B.
Assessment of injectable drug’s administration in two intensive care units and determination of potential physico-chemical incompatibilities.
EJHP Science 2006 ; 12,5: 96-99.
2231
ajaleht
de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S.
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3520
Labor
Cidomycin - Summary of product Chracteristics.
Sanofi 2011
3529
Labor
Ciprofloxacin – Summary of Product Characteristics
Hospira 2013
3545
Labor
Amoxicilline / acide clavulanique - Résumé des caractéristiques du produit
Mylan SAS 2009
3549
Labor
Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3643
Labor
Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
Sanofi 2015
3674
Labor
Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3791
plakat
Sadou Yaye H, Burtet E, Hamel C, Aljhni R, Gard C, Tilleul P.
Étude de la compatibilité physico-chimique du phloroglucinol injectable durant les mélanges au sein des tubulures en Y.
Apifh Congress, Paris November 2014 2014
3824
ajaleht
Boudi S, Roy H, Forest JM, Leclair G.
Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y.
Pharmactuel 2023 2023;56,3:91-98
3948
ajaleht
Bouchoud L, Fonzo-Christe C, Klingm?ller M, Bonnabry P .
Compatibility of Intravenous Medications With Parenteral Nutrition - In Vitro Evaluation.
JPEN 2012 ;30. 416?424.
4470
ajaleht
Claeysoone K, Basma V, Hens R, Van Bambeke F, de Jongh R, Tulkens P.
Continuous versus intermittent infusion of temocillin in intensive care unit patient.
Critical care 2005 ; 9(Suppl 1) P37
4524
plakat
Stucki C, Sautter A-M, Bonnabry P.
Physical compatibility of the propofol emulsion with 33 drugs used in anaesthesiology.
ESCP Symposium, Geneva, Switzerland 2009
4654
plakat
Sicard G, Donnette M, Martin N, Gensollen S, Pourroy B, Fanciullino R.
Compatibilité visuelle du Vyxeos® lors d'administration en Y avec une sélection de médicaments injectables.
Communication personnelle 2021
Mentions Légales